Ask AI
HORIZON-CRC01
HORIZON-CRC01: Phase III Trial of Trastuzumab Rezetecan vs SoC in Chemorefractory, HER2+ Advanced CRC

Released: June 16, 2026

Activity

Progress
1
Course Completed
Activity Information

Released: June 16, 2026